Schonfeld Strategic Advisors LLC Rubius Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.46 - $1.29 $276 - $774	-600 Reduced 3.82%	15,100 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.79 - $5.98 $12,403 - $93,886	15,700 New	15,700 $14,000
Q3 2021 Nov 16, 2021	SELL	$17.6 - $25.91 $160,160 - $235,781	-9,100 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$22.26 - $28.43 $202,566 - $258,713	-9,100 Reduced 50.0%	9,100 $222,000
Q2 2021 Aug 16, 2021	BUY	$22.26 - $28.43 $405,132 - $517,426	18,200 New	18,200 $444,000
Q4 2020 Feb 16, 2021	SELL	$4.23 - $8.73 $85,869 - $177,219	-20,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.65 - $6.25 $94,395 - $126,875	20,300 New	20,300 $0

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.